New shot aims to shield cancer patients from dangerous chemo side effect
NCT ID NCT07205536
Summary
This study is testing if a drug called mecapegfilgrastim can safely prevent a serious side effect of combined chemotherapy and radiation for chest cancers. The side effect, called myelosuppression, causes dangerously low white blood cell counts, increasing infection risk. Researchers will compare this new drug to standard treatments in 30 patients to see which is better at keeping blood counts stable.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMORADIOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Nantong University
RECRUITINGNantong, Jiangsu, 226001, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.